George Bertsias
Public Health, Environmental and Occupational Health · 2007–2023
A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Public Health, Environmental and Occupational Health — 15 citations into it
- Cardiology and Cardiovascular Medicine — 14 citations into it
Whom George Bertsias trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts George Bertsias overall
Papers from George Bertsias's perspective
Ordered by how strongly the researchers George Bertsias trusts endorse each paper. Same corpus, a different order for every researcher.
- Sequential therapies for proliferative lupus nephritis. (New England Journal of Medicine)
- Definition and initial validation of a Lupus Low Disease Activity State (LLDAS) (Annals of the Rheumatic Diseases)
- The classification of glomerulonephritis in systemic lupus erythematosus revisited. (Journal of the American Society of Nephrology)
- Neuromyelitis optica and non organ-specific autoimmunity. (Archives of Neurology)
- Syndromes of thrombotic microangiopathy. (New England Journal of Medicine)
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (International Journal of Behavioral Medicine)
- Protein kinase Cδ controls self-antigen-induced B-cell tolerance (Nature)
- Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular… (European Journal of Cardiovascular Prevention & Rehabilitation)
- Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. (New England Journal of Medicine)
- Lipoprotein(a) as a cardiovascular risk factor: current status (European Heart Journal)
Their papers
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 update (2023) — 846 citations
- 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis (2020) — 719 citations
- Update οn the diagnosis and management of systemic lupus erythematosus (2020) — 599 citations
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus (2019) — 1,638 citations
- 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus (2019) — 3,045 citations
- EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome (2015) — 790 citations
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force (2014) — 688 citations
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (2012) — 974 citations
- EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs (2010) — 736 citations
- EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (2007) — 752 citations